NCT04938466View on ClinicalTrials.gov

Assessment of Adherence, Quality of Life, Clinical Response and Safety of Daily and Long-Acting Growth Hormone Therapy

CompletedOBSERVATIONAL
Enrollment

19

Participants

Timeline

Start Date

August 5, 2021

Primary Completion Date

October 30, 2024

Study Completion Date

October 30, 2024

Conditions
Growth Hormone DeficiencyGrowth Hormone Treatment
Interventions
DRUG

Long-Acting Growth Hormone (LAGH)

Long-acting growth hormone (LAGH) treatment

Trial Locations (1)

55455

University of Minnesota, Minneapolis

All Listed Sponsors
lead

University of Minnesota

OTHER

NCT04938466 - Assessment of Adherence, Quality of Life, Clinical Response and Safety of Daily and Long-Acting Growth Hormone Therapy | Biotech Hunter | Biotech Hunter